search
US Food and Drug Administration
Trends
- 1
Reports say the US Food and Drug Administration has approved the first mRNA-based flu vaccine, marking a new application of the technology widely used in COVID-19 vaccines. The trending term reflects news headlines about the decision. Beyond the headline itself, the available posts contain no further details on the vaccine's maker, availability, or public reaction, so what people are saying beyond sharing the news is not clear from the posts.
- 2Former FDA chief says cyclosporiasis outbreak not fully under control▼Cyclosporiasis outbreak not 'fully under control,' former FDA chief says
A former head of the US Food and Drug Administration has warned that the ongoing cyclosporiasis outbreak in the United States is not 'fully under control,' despite official responses. The intestinal illness, typically linked to contaminated produce, has been the subject of public health tracking, and the comment raises concerns about the effectiveness of containment efforts so far.
- 3FDA links Ecuadorian black clams to hepatitis A outbreak▼FDA warns black clams from Ecuador tied to hepatitis A outbreak, 30 hospitalized
The US Food and Drug Administration has warned that black clams imported from Ecuador are linked to a hepatitis A outbreak that has hospitalized 30 people. Health authorities are urging consumers to avoid the shellfish while the investigation continues, and the warning has raised concerns about food safety controls in the seafood import supply chain.
- 4FDA announces nationwide cheese recall over E. coli outbreak▼FDA announces nationwide cheese recall after E. coli outbreak
The US Food and Drug Administration has announced a nationwide recall of cheese linked to an E. coli outbreak. The recall covers products distributed across the country, and consumers are being urged to check their purchases. Details on the brands affected and reported illnesses have not yet been fully disclosed.
- 5
The US Food and Drug Administration has released draft guidance for surgical robots, setting out proposed recommendations for devices used in robotic-assisted surgery. The guidance, reported by MedTech Dive, gives manufacturers and healthcare providers a framework to review. Stakeholders can weigh in before the agency finalizes its position.
- 6AbbVie wins FDA approval for new Parkinson's drug Juvmo●AbbVie lands FDA approval for next-generation Parkinson’s drug, Juvmo
AbbVie has received US Food and Drug Administration approval for Juvmo, described as a next-generation treatment for Parkinson's disease. The decision adds a new option to AbbVie's neurology portfolio and gives patients and doctors an additional therapy for managing the progressive movement disorder.
- 7FDA approves AbbVie's Parkinson's drug from Cerevel deal●AbbVie wins FDA approval for Parkinson’s drug from $8.7B Cerevel takeover
AbbVie has won US Food and Drug Administration approval for a Parkinson's disease treatment developed through its $8.7 billion acquisition of Cerevel Therapeutics. The approval validates the company's large bet on neurology and gives AbbVie a new product in a market where its flagship franchise faces eventual competition. Industry observers are watching how quickly the drug can reach patients and generate revenue.
- 8FDA Releases Draft Guidance for Cardiovascular Surgical Robots▼FDA shares draft guidance for cardiovascular surgical robots
The US Food and Drug Administration has issued draft guidance for cardiovascular surgical robots, outlining the agency's current thinking on the development and review of robotic systems used in cardiac and vascular procedures. The document gives manufacturers and clinicians a framework to follow, and a public comment period typically allows stakeholders to give feedback before the guidance is finalized.